Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01eff67f50c1f5112258c7cb8d640c13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_761b4765862a2eba5cc454d55c05a848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32f1009d2582e19a8fdce9a2934eb13f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ca0036143810c2a525b03363a4a0a5f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-59 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 |
filingDate |
1999-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a26d5f988d94111bd658fae9397d456 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82010e1b3317b58cd34c8f4bdd7c64ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13afc02fc5584a19ddc47dd30eb864a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0692a95db49722c5bedee5b42a96c7eb |
publicationDate |
1999-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9940079-A1 |
titleOfInvention |
Synthesis of dysidiolide and uses thereof |
abstract |
This invention provides a process for the preparation of a racemic mixture of dysidiolide a method for inhibiting growth of cancerous cells comprising contracting an amount of the racemic mixture of dysidiolide effective to inhibit the growth of said cells. Further provided is a method for treating cancer in a subject which comprises administering to the subject a therapeutically effective amount of the racemic mixture of dysidiolide. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006069787-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114306322-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114306322-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100395241-C |
priorityDate |
1998-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |